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ABSTRACT
Marginal structural models fit via inverse probability of treatment weighting are commonly used to
control for confounding when estimating causal effects from observational data. When planning a
study that will be analyzed with marginal structural modeling, determining the required sample size
for a given level of statistical power is challenging because of the effect of weighting on the variance
of the estimated causal means. This paper considers the utility of the design effect to quantify the
effect of weighting on the precision of causal estimates. The design effect is defined as the ratio of the
variance of the causal mean estimator divided by the variance of a naïve estimator if, counter to fact,
no confounding had been present and weights were not needed. A simple, closed-form approximation
of the design effect is derived that is outcome invariant and can be estimated during the study design
phase. Once the design effect is approximated for each treatment group, sample size calculations are
conducted as for a randomized trial, but with variances inflated by the design effects to account for
weighting. Simulations demonstrate the accuracy of the design effect approximation, and practical
considerations are discussed.
Keywords Causal inference · Design effect · Effective sample size · Hájek estimator · Inverse probability weighting
1 Introduction
Researchers often aim to estimate causal effects rather than just associations between variables. In settings where
experimental designs are implausible, inference relies on observational data from which measured associations can
be confounded. Marginal structural models (MSMs) are a commonly used method to estimate causal effects in the
presence of confounding variables [Hernán et al., 2000, Robins et al., 2000, Cole and Hernán, 2008, Brumback et al.,
2004]. These models are fit using weighted estimating equations, where the weights are the inverse of each participant’s
probability of the observed treatment (or exposure). For a binary treatment, the estimand of interest is often the average
causal effect, the difference in counterfactual means for the two treatment levels. With the assumptions of causal
consistency, conditional exchangeability, and positivity, the inverse probability of treatment weight (IPTW) estimators
are consistent for the MSM parameters for the causal means and the average causal effect [Lunceford and Davidian,
2004]. Variance estimates are computed using standard estimating equation theory [Stefanski and Boos, 2002], with the
empirical sandwich variance estimator providing a consistent estimator for the asymptotic variance of the estimated
average causal effect.
While IPTW estimators provide researchers with an analytic tool for estimating causal effects in the presence of
confounding variables, these estimators pose challenges during study design. The use of weights in the analysis affects
the variance of the average causal effect estimator, making it challenging to determine the number of participants needed
to achieve sufficient statistical power to detect a difference in causal means. Sample sizes cannot be calculated using
standard methods that ignore weighting as in a randomized controlled trial (RCT) [e.g. as in Chow et al., 2017], as
this will tend to be anti-conservative. Numerous papers have examined the properties of IPTWs and have developed
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guidelines and diagnostics for specifying weight models and adjusting estimated weights [Austin, 2009, Austin and
Stuart, 2015, Cole and Hernán, 2008, Lee et al., 2011]. However, currently no methods exist for power and sample size
calculations for studies that will be analyzed using MSMs fit with IPTWs.
Weighted estimators are common in survey sampling and for Bayesian methods that utilize importance sampling, and
both fields have developed methods to quantify the effect of weighting on the precision of estimates. Kish [1965,
page 257] introduced the design effect under the randomization-based inferential paradigm for survey sampling. The
design effect is the ratio of the variance of an estimator under a complex sample design to the variance of the estimator
under a simple random sample. When participants are selected directly from the finite population rather than from
clusters of correlated observations, the design effect for a population mean estimator simplifies to the design effect
due to weighting (deffw), or the unequal weighting effect [Kish, 1992]. Let n be the sample size and wi represent the
sampling weight for the ith participant, i.e., the inverse of participant i’s probability of selection. The design effect due
to weighting is defined using either of the two equivalent forms:
deffw =
n
∑n
i=1 wi
2
(
∑n
i=1 wi)
2
= 1 +
S2(w)
(n−1
∑n
i=1 wi)
2
(1)
where S2(w) is the finite sample variance of the weights. The design effect is interpreted as an estimator’s increase
in variance due to differential weights across participants. This metric is commonly applied to all types of complex
sample designs in which individuals in the finite population have different probabilities of selection [Valliant et al.,
2013, page 375]. Gabler et al. [1999] provided a justification for how Kish’s design effect also applies to model-based
estimators. In practice, the design effect is used to calculate the effective sample size, which is equal to the observed
sample size divided by the design effect. The effective sample size can be interpreted as the sample size under simple
random sampling that that would have produced the same variance as the sample selected under the complex design
[Valliant et al., 2013, page 5].
Bayesian importance sampling uses weighting methods when sampling from one distribution to estimate the properties
of another distribution [Kong et al., 1994]. Importance sampling uses the effective sample size metric to compare the
precision of the weighted estimator to the precision that would be achieved if sampling had been conducted directly
from the distribution of interest [Kong et al., 1994]. When the estimator of interest is a Hájek estimator, Kong [1992]
provides an approximation for the effective sample size which is a function of (1).
Advantages of the approximated design effect are that it is outcome invariant and allows the sample size under a
complex design to be translated into a sample size under a simpler design with the same variance. The former implies
that the approximated design effect depends only on the participants’ weights and is constant across outcomes. The
latter means that once deffw is known or approximated, it can be used in power and sample size calculations along
with the simpler assumptions needed to design a study without weights.
In this paper we consider design effects for planning observational studies to assess the effect of a treatment or exposure
on an outcome of interest. In the analysis of observational data, McCaffrey et al. [2004, 2013] have used the effective
sample size to quantify the loss of statistical precision following inference about causal effects using propensity score
weighting. Here we describe the use of design effects for determining the sample size or power when designing an
observational study. Section 2 introduces the design effect for causal inference and proves that it can be approximated
with Kish’s deffw. Section 3 demonstrates how the design effect can be used to determine the sample size or power
of an observational study that will be analyzed using MSM with IPTWs. Section 4 examines the accuracy of the
design effect approximation for various exposure and outcome types via simulations, and Section 5 provides practical
considerations regarding the use of design effects. Section 6 concludes with a discussion of the results and implications.
The Appendix includes proofs of the propositions appearing in the main text.
2 The Design Effect
2.1 Preliminaries
Suppose an observational study is being planned where n independent and identically distributed copies of (Ai, Li, Yi)
will be observed, where Ai is the binary treatment (exposure) status for participant i such that Ai = 1 if participant i
received treatment and Ai = 0 otherwise, Li is a vector of baseline covariates measured prior to Ai or unaffected by
treatment Ai, and Yi is the observed outcome for participant i.
The aim of the observational study will be to estimate the effect of treatment A on outcome Y . Specifically, let Y1i
denote the potential outcome if an individual i, possibly counter to fact, receives treatment. Similarly let Y0i denote the
potential outcome if individual i does not receive treatment, such that Yi = AiY1i + (1−Ai)Y0i. Inference from the
observational study will focus on parameters of the MSM E(Ya) = β0 + β1a, with particular interest in the parameter
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β1 which equals the average causal effect ACE = E(Y1)− E(Y0) = µ1 − µ0. Note the MSM is saturated and thus
does not impose any restrictions on the assumed structure of the data.
Under certain assumptions, the parameters of the MSM can be consistently estimated using IPTW. In particular, assume
conditional exchangeability holds, i.e., Ya ⊥ A | L for a ∈ {0, 1}. Also assume that positivity holds such that
Pr(A = a | L = l) > 0 for all l such that dFL(l) > 0 and a ∈ {0, 1}, where FL is the cumulative distribution function
of L. Estimating the average causal effect under the stated assumptions with the IPTW estimator first entails estimating
the propensity score for each participant, defined as pi = Pr(Ai = 1 | Li) [Rosenbaum and Rubin, 1983]. A model
is fit to obtain pˆi, each participant’s estimated probability of treatment conditional on observed covariates Li. The
estimated IPTW is then equal to Wˆi = I(Ai = 1)pˆ−1i + I(Ai = 0)(1− pˆi)−1, where I(Ai = a) is a {0,1} treatment
indicator for participant i. The estimated average causal effect βˆ1 is obtained by regressing the observed outcome Y
on treatment A with weights Wˆ using weighted least squares. The resulting IPTW estimator is a difference in Hájek
estimators for the two causal means [Hernán and Robins, 2020, Lunceford and Davidian, 2004]:
ÂCE = µˆ1 − µˆ0 =
∑n
i=1 WˆiYiI (Ai = 1)∑n
i=1 WˆiI (Ai = 1)
−
∑n
i=1 WˆiYiI (Ai = 0)∑n
i=1 WˆiI (Ai = 0)
(2)
Augmented IPW estimators, which incorporate both outcome and treatment models, may be used instead of (2) to
estimate the ACE. Such estimators are doubly robust and will be more efficient than (2) if both the treatment and
outcome models are correctly specified [Robins et al., 1994, Lunceford and Davidian, 2004]. Thus, the power and
sample size calculations derived below, which are based on (2), will be conservative for studies analyzed with augmented
IPW estimators.
2.2 The Design Effect for a Single Causal Mean
Define the design effect to equal the ratio of the (finite sample) variance of µˆa divided by the variance of a naïve causal
mean estimator if, counter to fact, no confounding was present and weighting was not needed. That is,
deffaw =
V ar(µˆa)
V ar(µ˜a)
(3)
where µ˜a = {
∑n
i=1 YiI(Ai = a)}/{
∑n
i=1 I(Ai = a)}. The derivation of the design effect estimator relies on the
following proposition. The proposition assumes that the weights are known and are denoted by Wa = P (A = a | L)−1
for a ∈ {0, 1} with W = AW1 + (1−A)W0. Let σ2a = V ar(Ya) for a ∈ {0, 1}.
Proposition 1 √
n(µˆa − µa) d→ N(0,Σa)
where
Σa = σ
2
a
(
E
{
W 2I(A = a)
}
[E {WI(A = a)}]2
)
+R(L, Ya)
and
R(L, Ya) = E[{Wa − E(Wa)}(Ya − µa)2]
with
|R(L, Ya)| ≤
√
V ar(Wa)V ar{Y 2a − 2µaYa}
for a ∈ {0, 1}
It follows from Proposition 1 that for large n the variance of µˆa can be approximated as:
V ar(µˆa) ≈ σ
2
a
n
(
E
{
W 2I(A = a)
}
[E {WI(A = a)}]2
)
+ n−1R(L, Ya)
By similar arguments, for large n, V ar(µ˜a) ≈ σ2a/{nP (A = a)}. Therefore,
deffaw ≈
P (A = a)E{W 2I(A = a)}
[E{WI(A = a)}]2 + Era (4)
where Era = {P (A = a)/σ2a}R(L, Y a), which by Proposition 1 is bounded by:
|Era| ≤ {P (A = a)/σ2a}
√
V ar(Wa)V ar(Y 2a − 2µaYa) (5)
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An approximation of (4) that does not depend on the potential outcome Ya omits the remainder term Era:
d˜eff
a
w =
P (A = a)E{W 2I(A = a)}
[E{WI(A = a)}]2 (6)
When planning an observational study, prior or pilot study data may be available to estimate (6). In particular,
suppose based on a pilot study np copies of (Li, Ai) are observed. Then replacing P (A = a) with Na/np
where Na =
∑np
i=1 I(Ai = a), E{W 2I(A = a)} with n−1p
∑np
i=1 Wˆ
2
i I(Ai = a), and E{WI(A = a)} with
n−1p
∑np
i=1 WˆiI(Ai = a), a consistent estimator of (6) is:
d̂eff
a
w =
Na
∑np
i=1 Wˆ
2
i I(Ai = a){∑np
i=1 WˆiI(Ai = a)
}2 (7)
This estimator has the same form as Kish’s design effect (1), applied to treatment group A = a. When prior data are not
available, the design effect can be approximated using (6) based on an assumed distribution for A | L and the marginal
distribution of L. The bias of (6) or (7) as an approximation to (4) in a given application depends on the value of Era.
As further discussed in Section 6, Era is not guaranteed to be negligible. Bias of (6) and (7) for varying outcome types
and confounding structures is evaluated empirically in simulation studies presented in Section 4.
3 Sample Size Calculations using the Design Effects
When the ACE is the focus of inference for the observational study being planned, the large sample distribution of
ÂCE can be used for power or sample size calculations. As n→∞, ÂCE is consistent and asymptotically normal,
i.e.,
√
n(ÂCE −ACE) d→ N(0,Σ∗), where Σ∗ is given by equation (13) in Lunceford and Davidian [2004]. By the
following proposition, Σ∗ can be decomposed into the sum of asymptotic variances for the two causal mean estimators:
Proposition 2
Σ∗ = Σ1 + Σ0
Treating the weights as fixed or known leads to a larger asymptotic variance for ÂCE compared to appropriately
treating the weights as estimated, i.e., Σ∗ is at least as large as the true asymptotic variance of ÂCE [Lunceford and
Davidian, 2004]. Therefore, sample size formulae derived based on Σ∗ would in general be expected to be conservative.
The results in Propositions 1 and 2 allow for sample size calculations for studies that will be analyzed using MSM with
IPTW. Suppose the sample size for the observational study being planned is to be determined on the basis of the power
to test H0 : ACE = 0 versus Ha : ACE 6= 0 or equivalently H0 : β1 = 0 versus Ha : β1 6= 0. Define the test statistic
t = ÂCE{V ar(ÂCE)}−1/2, where
V ar(ÂCE) ≈ V ar(µˆ1) + V ar(µˆ0) ≈ {nP (A = 1)}−1σ21,adj + {nP (A = 0)}−1σ20,adj (8)
with σ2a,adj = σ
2
adeff
a
w for a ∈ {0, 1}. Then,
ÂCE −ACE√
V ar(ÂCE)
(9)
is approximately standard normal for large n. Thus, H0 is rejected when |t| > z1−α2 , where α is the type I error rate
and zq is the qth quantile of the standard normal distribution.
Proposition 3 The sample size required to achieve power 1 − β for effect size ACE = δ and type I error rate α is
approximately:
ndeff =
(1 + k)(z1−α/2 + z1−β)2(σ21,adj/k + σ
2
0,adj)
δ2
(10)
where k = P (A = 1)/P (A = 0) is the odds of treatment in the population.
The sample size formula (10) is the standard sample size equation commonly used to design RCTs, but with σ2a
replaced by σ2a,adj [Chow et al., 2017, page 48]. Thus, Proposition 3 simplifies power and sample size calculations
for observational studies by allowing researchers to design studies as if they were designing an RCT, but inflating the
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assumed variances by the approximated design effects. The researcher first assumes that no confounding is present,
specifies the desired α and 1−β, and makes assumptions about σ20 , σ21 , δ, and k. The design effect is then approximated.
When data from a pilot or prior study are available, deff1w and deff
0
w can be approximated based on (7) for each
treatment group. When no prior study data are available, the distribution of the anticipated weights can be estimated
based on assumptions about the distribution of L and A | L and the design effect can be calculated based on (6). While
these assumptions may not be easy to make, this approach notably requires no assumptions about the potential outcomes
Y0 and Y1 and their associations with A and L. Further discussion about these practical considerations is included in
Section 5. Once the design effects are approximated by d˜eff
a
w or d̂eff
a
w, adjusted variances σ
2
a,adj can be estimated
by σ˜2a,adj = σ
2
ad˜eff
a
w or σˆ
2
a,adj = σ
2
ad̂eff
a
w, respectively, for a ∈ {0, 1}.
4 Simulation Study
4.1 Simulation Scenarios
Simulation studies were conducted to demonstrate use of the design effect in study design and estimate the bias of the
approximation in (6) and (7) under a variety of confounding structures and outcome types. The scenarios in Table 1
were considered. For all scenarios, α = 0.05 and 1− β = 80% were chosen.
Table 1: Five simulation scenarios. Scenarios 1-4 demonstrate use of the design effect when no prior study data are
available, and Scenario 5 demonstrates use of the design effect with prior study data. X ∼ B(p) indicates that a random
variable X follows the Bernoulli distribution with probability of success equal to p.
Scenario Exposure (A) Confounders (L) Outcome (Y ) δ
1 binary Y ,small deffaw
A | L = 0 ∼ B(0.5)
A | L = 1 ∼ B(0.75) L ∼ B(0.6)
Y0 | L ∼ B(0.85− 0.2L)
Y1 | L ∼ B(0.70− 0.2L) −0.15
2 binary Y ,large deffaw
A | L = 0 ∼ B(0.1)
A | L = 1 ∼ B(0.9) L ∼ B(0.5)
Y0 | L ∼ B(0.85− 0.2L)
Y1 | L ∼ B(0.70− 0.2L) −0.15
3 continuous Y ,small deffaw
A | L = 0 ∼ B(0.5)
A | L = 1 ∼ B(0.75) L ∼ B(0.6)
Y0 | L ∼ N(20− 10L, 144)
Y1 | L ∼ N(25− 10L, 256) 5.0
4 continuous Y ,large deffaw
A | L = 0 ∼ B(0.1)
A | L = 1 ∼ B(0.9) L ∼ B(0.5)
Y0 | L ∼ N(20− 10L, 144)
Y1 | L ∼ N(25− 10L, 256) 5.0
5 prior study data(NHEFS) smoking cessation
9 baseline
variables weight gain 2.0
4.2 Sample Size Calculation
Two general approaches can be used to design a study with the design effect approximation: when prior study data are
not available, as in Scenarios 1-4, and when prior study data are available, as in Scenario 5. One example from each
general approach is presented in detail.
4.2.1 Example 1: No prior study data (Scenario 1)
Suppose no prior study data are available to design the study of interest. Then, the researcher must make the same
assumptions and design choices as when designing an RCT, namely by specifying α, 1 − β, σ20 , σ21 , δ, and k. In
general, σ21 can be determined by deriving the marginal distribution of Y1 based on the assumed distributions of
Y1 | L and L. For Scenario 1, P (Y1 = 1) =
∑1
l=0 P (Y1 = 1 | L = l)P (L = l) = 0.58, and thus σ21 = 0.2436.
Similarly, σ20 = 0.1971. Here, the average causal effect is assumed to be δ = −0.15. The proportion of the
population receiving treatment can be derived by integrating the distribution of A | L over L. For Scenario 1,
P (A = 1) =
∑1
l=0 P (A = 1 | L = l)P (L = l) = 0.65, and thus k ≈ 1.857. When prior study data are not available,
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the distribution of the IPTWs must be assumed at the design phase. Based on the assumptions in Table 1, four possible
values of W exist. These assumed values of W , along with the joint distribution of A and L, allow for the computation
of the design effects using (6). This leads to d˜eff
0
w = 1.12 and d˜eff
1
w = 1.04, with approximated adjusted variances
of σ˜20,adj = 0.2208 and σ˜
2
1,adj = 0.2533.
Under the assumptions outlined in Table 1 for Scenario 1, to achieve 80% power to detect an average causal effect of
−0.15 at the α = 0.05 level, a sample size of approximately ndeff = 356 is required based on Proposition 3. The
design effects and required sample sizes for Scenarios 2-4 can be determined similarly and are presented in Table 2.
Note Scenarios 1 and 3 have the same design effects because in both instances the joint distribution of A and L is the
same. Likewise, Scenarios 2 and 4 have the same design effects.
4.2.2 Example 2: Prior study data (Scenario 5)
Prior study or pilot data may allow for better informed assumptions about σ20 , σ
2
1 , δ, and k. Because σ
2
a = E(Y
2
a )−
{E(Ya)}2, σ2a can be estimated by obtaining Eˆ(Y 2a ) and Eˆ(Ya) from fitted MSMs based on the prior study data. The
estimate ÂCE and prevalence of the exposure or treatment in the prior study can inform assumptions about δ and k.
As an example, consider designing a new study based on the National Health and Nutrition Examination Survey Data I
Epidemiologic Follow-up Study (NHEFS) example presented in Chapter 12 of Hernán and Robins [2020]. Hernán
and Robins use MSM with IPTWs to estimate the average causal effect of smoking cessation (A) on weight gain after
approximately 10 years of follow-up (Y ) based on the NHEFS sample of smokers (n = 1566), assuming conditional
exchangeability based on nine baseline confounders L: sex, age, race, education, smoking intensity, duration of smoking,
physical activity, exercise, and weight.
Making the same assumptions as Hernán and Robins [2020], Scenario 5 considers the design of a new study to estimate
the average causal effect of smoking cessation on 10-year weight gain. Based on the NHEFS data, assume that
σ20 = 56.1 and σ
2
1 = 74.0, obtained by fitting MSMs with IPTWs to estimate E(Y
2
a ) and E(Ya). In the Hernán and
Robins example, ÂCE = 3.441kg. The new study will be designed to provide approximately 80% power to detect a
difference in weight gain of δ = 2.0kg. From the NHEFS sample, assume k ≈ 0.346.
When prior study data are available, deff0w and deff
1
w can be estimated using (7). For the NHEFS data, d̂eff
0
w = 1.03
and d̂eff
1
w = 1.24. This leads to approximated adjusted variances of σˆ
2
0,adj = 57.78 and σˆ
2
1,adj = 91.76. Based on
these assumptions, a sample size of ndeff = 853 is needed to achieve approximately 80% power to detect an average
causal effect of 2.0kg at the α = 0.05 level using MSM with IPTWs.
4.2.3 Naïve Sample Size Calculations
As a comparison, sample sizes nrct were calculated naively under the assumptions of an RCT, ignoring the effect of
weighting on the variances of the estimates. In other words, sample sizes were calculated as demonstrated above, except
using σ2a instead of σ˜
2
a,adj or σˆ
2
a,adj from Table 2.
4.3 Evaluation
For Scenarios 1-4, empirical power based on samples of size ndeff was evaluated via simulation by following these
steps:
(i) Generate a superpopulation of size N = 1, 000, 000 based on distributions in Table 1.
(ii) Select a sample of size ndeff without replacement from the superpopulation, where ndeff is specified in Table
2.
(iii) Estimate Wˆi for each member of the sample based on the predicted values from the logistic regression of A on
L.
(iv) Fit the MSM E(Yai) = β0 + β1ai using weighted least squares, treating the weights as estimated by stacking
the estimating equations from the weight model with the estimating equations for the causal means and
difference in causal means using the geex package in R [Saul and Hudgens, 2020].
(v) Test H0 : β1 = 0 versus H1 : β1 6= 0 using a Wald test, rejecting H0 at the α = 0.05 significance level.
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Table 2: Variances, approximated design effects, approximated adjusted variances, and required sample sizes for
simulation scenarios by treatment.
Scenario a σ2a d˜eff
a
w or d̂eff
a
w σ˜
2
a,adj or σˆ
2
a,adj ndeff nrct
1 binary Y ,small deffaw
0
1
0.1971
0.2436
1.12
1.04
0.2208
0.2533
356 327
2 binary Y ,large deffaw
0
1
0.1875
0.2400
2.78
2.78
0.5208
0.6667
828 298
3 continuous Y ,small deffaw
0
1
168.0
280.0
1.12
1.04
188.2
291.2
310 286
4 continuous Y ,large deffaw
0
1
169.0
281.0
2.78
2.78
469.4
780.6
784 283
5 prior study data,(NHEFS)
0
1
56.10
74.00
1.03
1.24
57.78
91.76
853 713
(vi) Repeat steps (ii)-(v) R = 2000 times and calculate empirical power as the proportion of simulated samples
where H0 was rejected.
For Scenario 5, empirical power based on a sample of size ndeff was evaluated via simulation by following these steps:
(i) Estimate the propensity score for each of the 1566 NHEFS participants from a logistic regression model of A
on L as pˆi = P̂ r(Ai = 1 | Li = li). As in Hernán and Robins [2020], the logistic regression model includes
main effects for each of the nine baseline confounders and quadratic terms for the four continuous covariates.
(ii) For each participant, calculate Yˆai, a ∈ {0, 1}, as the predicted value Eˆ(Yai | Li = li) from the following
linear regression model, fit only on participants with A = a: E(Yai | Li = li) = liβ, where li is a vector for
participant i that includes an intercept term, the 9 previously defined covariates, and the four quadratic terms
corresponding to continuous covariates. Also compute V̂ ar(Yai | Li = li) = MSEa, where MSEa is the
mean squared error from the model for E(Yai).
(iii) Add 1.441 to Yˆ0i for all participants, such that ACE = 2.0 in the simulated population instead of 3.441 as in
the NHEFS sample.
(iv) Select a sample of size ndeff with replacement from the NHEFS dataset, where ndeff is specified in Table 2.
(v) Assign Ai = ai as a random draw from Ai ∼ Bernoulli(pˆi).
(vi) Let Yai = Yˆai + ai, where ai ∼ N(0, V̂ ar(Yai | Li = li)).
(vii) Follow steps (iii)-(v) from the above list for Scenarios 1-4.
(viii) Repeat steps (iv)-(vii) R = 2000 times and estimate empirical power as the proportion of simulated samples
where H0 was rejected.
For each scenario, these steps were repeated to calculate empirical power based on the naïve sample sizes, replacing
ndeff with nrct.
The results of the simulation study are presented in Table 3. For all simulation scenarios, when the sample size was
calculated using the design effect, empirical power was equal to or exceeded the nominal 80% level. That is, use of the
design effects to calculate required sample sizes led to close to the intended level of statistical power. On the other hand,
ignoring the effect of weighting and basing sample sizes on the naïve assumptions of an RCT led to empirical power
that was lower than the nominal 80% level for all but one scenario. These results demonstrate that ignoring the weights
in power and sample size calculations can lead to significantly underpowered studies, particularly when there are strong
confounders that lead to high variability in the weights.
For all scenarios, the approximation errors Era from (4) for each sample and treatment were estimated by Êra =
{Na/(nσ2a)}Eˆ
[
{Wˆa − Eˆ(Wˆa)}{Ya − Eˆ(Ya)}2
]
, where expected values were calculated empirically within each
sample. Estimated approximation errors were then averaged across the R = 2000 simulated samples. Mean estimated
approximation error was small for most scenarios (Table 3) and was in opposite directions for the two treatment groups,
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which tended to offset the effects of the errors. Approximation error was large for Scenario 2 (0.60 for A = 0 and
−0.19 for A = 1), but empirical power still equaled the nominal level when the design effect was used to calculate the
sample size. Note Scenario 2 is an extreme example, as it includes only a single and very strong confounding variable
and only two possible and extreme values for W . For the binary outcome, this resulted in large approximation errors.
Table 3: Results of the simulation study by scenario across R = 2000 samples. Empirical power ndeff and nrct are the
proportions of simulated samples in which the p-values for testing H0 : β1 = 0 versus H1 : β1 6= 0 were less than
α = 0.05 for the following MSM: E(Yai) = β0 + β1ai, based on sample sizes ndeff and nrct, respectively, from
Table 2
Scenario
Empirical
Power
ndeff
Empirical
Power
nrct
Mean
Êr0
Mean
Êr1
1 0.81 0.76 0.08 -0.01
2 0.80 0.42 0.60 -0.19
3 0.85 0.81 -0.02 0.01
4 0.86 0.47 0.00 -0.01
5 0.82 0.76 0.02 -0.03
5 Practical Considerations
When prior study data are not available, specifying the design effects can be challenging. A few general guidelines are
offered to help researchers determine reasonable assumptions to facilitate power and sample size calculations.
When only a few categorical covariates will be included in the weight model, researchers can use subject matter
knowledge or prior study information to nonparametrically specify the joint distribution of A and L, or the marginal
distribution of L and the conditional distribution ofA | L (as in Example 1). Based on these assumptions, the anticipated
weights can be calculated nonparametrically and the design effects for each treatment group can be approximated.
When specification of these distributions is not feasible, researchers can forgo approximating the values of the weights
and instead consider more generally how much variation is expected in the weights. The lower bound for deffaw is
1, which implies that the weights within both treatment groups are all equal and thus covariates are not predictive of
the treatment. Design effects tend to increase when more covariates are added to the weight model. The presence of
covariates that are strong predictors of treatment tends to increase the design effect. Care must be taken to identify the
appropriate set of confounders to include in the weight model [Vansteelandt et al., 2012]. Inclusion of instrumental
variables, which are predictive of the exposure but which do not affect the outcome, inflate the variance of the ACE
estimator without reducing bias [Rubin, 1997, Myers et al., 2011]. The use of weight truncation will decrease the design
effect.
Figure 1 provides a visual depiction of weight distributions within one treatment group for various values of the design
effect to aid researchers in choosing a design effect consistent with the expected variation in the weights. These weight
distributions were generated by taking the reciprocals of Na = 1000 random draws from beta distributions with mean
0.5 and shape parameters set to achieve the desired design effect. As variation in the weights increases, so does the
design effect approximation.
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Figure 1: Examples of weight distributions for various approximated design effects. Distributions were generated by
taking the reciprocals of Na = 1000 random draws from beta distributions with mean 0.5 and shape parameters set to
achieve the desired design effect.
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6 Discussion
The design effect approximation simplifies power and sample size calculations of observational studies. Using the
design effect allows researchers to utilize standard power and sample size software (e.g., nQuery, SAS Proc Power) for
randomized trials, but with variances inflated by the approximate design effects. An additional advantage of using the
design effect approximation is that no assumptions are required about the relationship between the potential outcomes
and either the treatment or the confounders. Empirical results presented in Section 4 demonstrate the design effect
approximation can yield the nominal level of power over a range of confounding and outcome structures.
Approximating the design effect when planning an observational study may be challenging. In survey sampling, it is
common practice to report estimated design effects in analytic reports for better understanding of the precision of the
estimates and to assist other researchers who are designing similar studies [see, for example Center for Behavioral
Health Statistics and Quality, 2019]. Reporting the estimated design effects corresponding to treatment or exposure
effect estimates in observational studies may assist researchers with future study designs. In time, as more studies
analyzed with MSMs start to report their design effects, rules of thumb and practical upper bounds for the design effects
will likely emerge to aid in the design of future studies (see, for example, United Nations Statistical Division [2008,
page 41], Daniel [2012, page 251], and Salganik [2006] from the survey sampling literature).
In the absence of knowledge of estimated design effects from prior studies, the design effect may be approximated either
using (6) or, if pilot data are available, (7). In either case, the remainder term in (4) is ignored, which may introduce
bias. The remainder may be large when individuals with extreme weight values tend to have potential outcomes that are
also extreme relative to the mean. In the simulation studies in Section 4, the approximation error was small for all but
one of the scenarios examined. Remainders were in opposite directions for the two treatment groups, which tended to
offset the effects of the errors and thus use of the approximation did not result in deviations from the nominal level of
statistical power for any of the scenarios examined. However, there is no guarantee that approximation error will be
negligible for a given study. When pilot or prior study data are available, approximation error Era can be estimated as
in the simulations, but with Ya replaced with Yˆa for a ∈ {0, 1} where Yˆa is based on an assumed outcome regression
model. Alternatively, an estimate for the upper bound of Era can be obtained by estimating the upper bound in (5).
Despite these limitations, the design effect approximation can be a useful tool for the design of studies that will be
analyzed using MSM with IPTWs, as currently no power and sample size methods exist in this context. The design
effect can also be used in precision calculations using approaches analogous to those described in this paper, i.e., basing
calculations on the adjusted variances σ˜2a,adj or σˆ
2
a,adj rather than σ
2
a.
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Appendix
Proof of Proposition 1
Without loss of generality, consider a = 1. Let Xi = W1iYiAi and Zi = W1iAi. The asymptotic distribution of
µˆ1 =
∑n
i=1Xi/
∑n
i=1 Zi can be derived using the multivariate delta method [Kong, 1992]. Let
Tn =
(
1
n
∑n
i=1Xi
1
n
∑n
i=1 Zi
)
, θ =
(
µx
µz
)
, g(θ) =
µx
µz
, ∇g(θ) =
( 1
µz−µxµ2z
)
,
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and
Σ =
(
V ar(X) Cov(X,Z)
Cov(Z,X) V ar(Z)
)
where µx = E (Xi), µz = E (Zi), and ∇g(θ) is the gradient vector for g(θ). From the bivariate central limit theorem,√
n(Tn−θ) d→ N2(0,Σ). Applying the multivariate delta method,
√
n{g(Tn)−g(θ)} d→ N(0,Σ1) where g(Tn) = µˆ1
and
Σ1 = ∇g(θ)TΣ∇g(θ) =
(
µx
µz
)2{
V ar (X)
µ2x
+
V ar(Z)
µ2z
− 2Cov (X,Z)
µxµz
}
Dropping subscripts i for notational ease, note that:
µz = E (Z) = E (W1A) = EL
{
EA|LA
P (A = 1 | L)
}
= 1
and from Hernán and Robins [2020] Technical Point 2.3, µx = E (X) = E (W1AY1) = µ1. Then,
Σ1 = V ar (W1AY1) + µ
2
1V ar (W1A)− 2µ1Cov (W1AY1,W1A) (A.1)
A simpler form for Σ1 is derived by rewriting the components of (A.1) using the following results. First note that
Cov (W1AY1,W1A) = E {(W1AY1) (W1A)} − E (W1AY1)E(W1A) = E
(
W 21AY1
)− µ1
= EL
{
EA|LA EY1|LY1
P (A = 1 | L)2
}
− µ1 = EL
{
EY1|LY1
P (A = 1 | L)
}
− µ1
= E (W1Y1)− µ1 (A.2)
Also note that
V ar (W1AY1) = E
(
W 21AY
2
1
)− {E (W1AY1)}2
= EL
{
EA|LA EY1|LY
2
1
P (A = 1 | L)2
}
− µ21 = EL
{
EY1|LY
2
1
P (A = 1 | L)
}
− µ21
= E
(
W1Y
2
1
)− µ21 (A.3)
By the law of total variance:
V ar(W1A) = E{V ar(W1A | L)}+ V ar{E(W1A | L)} = E(W1)− 1 (A.4)
Therefore, plugging (A.2), (A.3), and (A.4) into (A.1),
Σ1 = E(W1Y
2
1 )− µ21 + µ21{E(W1)− 1} − 2µ1{E (W1Y1)− µ1}
= E(W1Y
2
1 ) + µ
2
1E(W1)− 2µ1E(W1Y1) (A.5)
Next define R = E[{W1 − E(W1)}(Y1 − µ1)2] and note that
R = E(W1Y
2
1 )− 2µ1E(W1Y1)− E(Y 21 )E(W1) + 2µ21E(W1) (A.6)
From (A.5) and (A.6) it follows that
Σ1 = E(W1)E(Y
2
1 )− E(W1)µ21 +R = E(W1)σ21 +R
= σ21E(W
2
1A) +R = σ
2
1
[
E(W 21A)
E(W1A)
]
+R
= σ21
[
E(W 2A)
{E(WA)}2
]
+R
Bounds for R follow from the Cauchy-Schwarz inequality:
|R| = |Cov(W1, Y 21 − 2µ1Y1)| ≤
√
V ar(W1)V ar(Y 21 − 2µ1Y1)
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Proof of Proposition 2
From equation (13) in Lunceford and Davidian [2004],
Σ∗ = E{W1(Y1 − µ1)2 +W0(Y0 − µ0)2}
Note
E{W1(Y1 − µ1)2} = E(W1Y 21 )− 2µ1E(W1Y1) + µ21E(W1)
which equals Σ1 by (A.5). Similarly, E{W0(Y0 − µ0)2} = Σ0, proving the proposition.
Proof of Proposition 3
Let 1− β denote the power to detect a difference in causal means of size δ, i.e.,
1− β = P (|t| > z1−α/2 | ACE = δ)
= P
 ÂCE − δ√
V ar(ÂCE)
> z1−α/2 − δ√
V ar(ÂCE)
∣∣∣∣ACE = δ

+ P
 ÂCE − δ√
V ar(ÂCE)
< zα/2 − δ√
V ar(ÂCE)
∣∣∣∣ACE = δ

In large samples, (9) is approximately standard normal. Thus,
1− β ≈ 1− Φ
z1−α/2 − δ√
V ar(ÂCE)
+ Φ
zα/2 − δ√
V ar(ÂCE)
 (A.7)
where Φ(∗) represents the cumulative distribution function for the standard normal evaluated at ∗. Without loss of
generality, assume δ > 0. Then the second component on the right side of (A.7) will be less than α/2 and often close to
zero. Therefore,
zβ ≈ z1−α/2 − δ√
V ar(ÂCE)
(A.8)
Define k = P (A = 1)/P (A = 0). Given that V ar(ÂCE) ≈ {nP (A = 1)}−1σ21,adj + {nP (A = 0)}−1σ20,adj and
solving (A.8) for n yields (10).
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